Compounds > glucuronic acid
Page last updated: 2024-08-24

glucuronic acid and Autoimmune Diabetes

glucuronic acid has been researched along with Autoimmune Diabetes in 51 studies

Research

Studies (51)

TimeframeStudies, this research(%)All Research%
pre-19902 (3.92)18.7374
1990's7 (13.73)18.2507
2000's13 (25.49)29.6817
2010's29 (56.86)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cañibano-Hernández, A; Ciriza, J; Espona-Noguera, A; Fernandez, L; Ochoa, I; Pedraz, JL; Saenz Del Burgo, L1
Calafiore, R2
Chintinne, M; Delvaux, G; Gillard, P; Gorus, F; Jacobs-Tulleneers-Thevissen, D; Keymeulen, B; Ling, Z; Pipeleers, D; Schoonjans, L; Strand, BL1
Weir, GC1
Aimetti, AA; Anderson, DG; Cheng, H; Dang, TT; Gu, Z; Langer, RS; Veiseh, O; Wang, Q; Zhang, Y1
Farney, AC; Opara, EC; Pareta, RA1
Byun, Y; Jeong, JH; Lee, DY; Lee, M; Park, JB1
Hallé, JP; Neufeld, RJ; Poncelet, D; Steele, JA1
Basta, G; Calafiore, R2
Dolgin, E2
Al-Salami, H; Chen-Tan, N; Golocorbin-Kon, S; Lalic-Popovic, M; Martinez, J; Mathavan, S; Mikov, M; Mooranian, A; Mukkur, TK; Negrulj, R; Sciarretta, J; Stojancevic, M1
Al-Salami, H; Al-Sallami, HS; Arfuso, F; Chen-Tan, N; Fakhoury, M; Fang, Z; Golocorbin-Kon, S; Mikov, M; Mooranian, A; Mukkur, T; Negrulj, R1
Al-Salami, H; Al-Sallami, HS; Arfuso, F; Aruso, F; Fakhoury, M; Fang, Z; Golocorbin-Kon, S; Mikov, M; Mooranian, A; Negrulj, R1
Al-Salami, H; Arfuso, F; Chen-Tan, N; Mathavan, S2
Cho, JH; Ham, DS; Hong, TH; Khang, G; Kim, JW; Kim, MJ; Kim, OY; Lee, SH; Park, HS; Rhee, M; Shin, J; Yang, HK; Yoon, KH; You, YH1
Chen, Z; Cheng, D; Dong, L; Gao, Y; Han, Y; Xu, H; Yao, J; Yi, T; Yin, N1
Keymeulen, B; Pipeleers, D1
Alexander, M; Chan, KH; Krishnan, R; Lakey, JRT1
Kendall, WF; Opara, EC1
de Haan, B; De Vos, P; Foster, CE; Ko, D; Krishnan, R; Lakey, JR; Liu, W; Smink, AM1
Matsumoto, S; Shimoda, M1
Barbaro, B; Benedetti, E; Gangemi, A; Hansen, MA; Hunkeler, D; Kuechle, J; Lacík, I; Mørch, Y; Oberholzer, J; Qi, M; Rodriguez, LA; Romagnoli, T; Salehi, P; Skjåk-Braek, G; Strand, BL; Wang, Y1
Höcht, B; Meyer, T; Ulrichs, K1
Foster, JL; Keogh, GW; Philips, R; Tuch, BE; Vaithilingam, V; Williams, LJ; Wu, W1
Basta, G; Becchetti, E; Blasi, P; Calafiore, R; Calvitti, M; Fallarino, F; Giovagnoli, S; Luca, G; Mancuso, F; Ricci, M; Rossi, C1
Guillemin, GJ; Oberholzer, J; Tuch, BE; Vaithilingam, V1
Gao, Y; Li, G; Lim, SK; Shao, S; Xie, B; Xie, F1
Ngoc, PK; Nguyet, NT; Nhung, TH; Phuc, PV; Thuy, DT1
Evans, MD; Hughes, TC; Tuch, BE1
Childers, C; Mirmalek-Sani, SH; Opara, EC; Ramasubramanian, MK; Saul, J; Tendulkar, S1
Bresson, R; Charpentier, P; Coliche, V; Erlher, S; Ha Van, G; Lalau, JD; Magalon, G; Martini, J; Moreau, Y; Pradines, S; Richard, JL; Rigal, F; Wemeau, JL1
Sambanis, A2
Basta, G; Brunetti, P; Calabrese, G; Calafiore, R; Guido, L; Luca, G; Macchiarulo, G; Mancuso, F; Nastruzzi, C; Racanicchi, L; Sarchielli, P1
Darrabie, MD; El-Shewy, HM; Kendall, WF; Opara, EC1
Lawrie, G; Leung, A; Munro, P; Nielsen, L; Ramaswamy, Y; Trau, M1
Cheng, SY; Constantinidis, I; Sambanis, A1
Gold, L; Merimee, TJ; Misbin, RI1
Espevik, T; Følling, I; Kulseng, B; Skjåk-Braek, G1
De Haan, BJ; De Vos, P; Strubbe, JH; Van Schilfgaarde, R; Wolters, GH1
Brotzu, G; Cappai, A; Dessy, E; Petruzzo, P; Rescigno, A; Ruiu, G1
Hunter, SK; Niebyl, J; Wang, Y; Weiner, CP1
Beutner, U; Bühler, C; Hamelmann, W; Klöck, G; Meyer, T; Otto, C; Thiede, A; Ulrichs, K1
Duvivier-Kali, VF; O'Neil, JJ; Omer, A; Parent, RJ; Weir, GC1
Bell, PR; Clayton, HA; Colloby, PS; James, RF; London, NJ1
Darquy, S; Reach, G1

Reviews

8 review(s) available for glucuronic acid and Autoimmune Diabetes

ArticleYear
Design of a bioartificial pancreas.
    Pathobiology : journal of immunopathology, molecular and cellular biology, 2013, Volume: 80, Issue:4

    Topics: Alginates; Diabetes Mellitus, Type 1; Drug Compounding; Glucuronic Acid; Graft Rejection; Hexuronic Acids; Humans; Islets of Langerhans Transplantation; Pancreas; Pancreas, Artificial

2013
Therapeutic cell encapsulation techniques and applications in diabetes.
    Advanced drug delivery reviews, 2014, Volume: 67-68

    Topics: Alginates; Animals; Diabetes Mellitus, Type 1; Emulsions; Glucuronic Acid; Hexuronic Acids; Humans; Islets of Langerhans Transplantation; Pancreas; Pancreas Transplantation; Static Electricity; Tissue Scaffolds

2014
Clinical application of microencapsulated islets: actual prospectives on progress and challenges.
    Advanced drug delivery reviews, 2014, Volume: 67-68

    Topics: Alginates; Animals; Diabetes Mellitus, Type 1; Glucuronic Acid; Hexuronic Acids; Humans; Immunosuppression Therapy; Islets of Langerhans; Islets of Langerhans Transplantation; Polyethylene Glycols

2014
Immunological Challenges Facing Translation of Alginate Encapsulated Porcine Islet Xenotransplantation to Human Clinical Trials.
    Methods in molecular biology (Clifton, N.J.), 2017, Volume: 1479

    Topics: Alginates; Animals; Cells, Immobilized; Clinical Trials as Topic; Diabetes Mellitus, Type 1; Glucuronic Acid; Graft Rejection; Graft Survival; Hexuronic Acids; Humans; Immunosuppression Therapy; Islets of Langerhans; Islets of Langerhans Transplantation; Mesenchymal Stem Cell Transplantation; Mesenchymal Stem Cells; Swine; Transplantation, Heterologous; Treatment Outcome

2017
Encapsulated islets in diabetes treatment.
    Diabetes technology & therapeutics, 2003, Volume: 5, Issue:4

    Topics: Alginates; Animals; Biocompatible Materials; Capsules; Diabetes Mellitus, Type 1; Disease Models, Animal; Glucuronic Acid; Hexuronic Acids; Humans; Islets of Langerhans Transplantation

2003
Actual perspectives in biohybrid artificial pancreas for the therapy of type 1, insulin-dependent diabetes mellitus.
    Diabetes/metabolism reviews, 1998, Volume: 14, Issue:4

    Topics: Acrylates; Acrylic Resins; Alginates; Biocompatible Materials; Blood Vessel Prosthesis; Capsules; Cellulose; Diabetes Mellitus, Type 1; Glucuronic Acid; Hexuronic Acids; Humans; Islets of Langerhans; Microspheres; Pancreas, Artificial; Polytetrafluoroethylene; Polyvinyl Chloride; Transplantation, Heterologous

1998
[Transplantation of porcine Langerhans islets for therapy of type I diabetes. The way to clinical application].
    Zentralblatt fur Chirurgie, 1999, Volume: 124, Issue:7

    Topics: Alginates; Animals; Antibodies, Heterophile; Biocompatible Materials; Capsules; Diabetes Mellitus, Type 1; Glucuronic Acid; Graft Survival; Hexuronic Acids; Humans; Islets of Langerhans Transplantation; Swine; Transplantation, Heterologous

1999
Engineering challenges in the development of an encapsulated cell system for treatment of type 1 diabetes.
    Diabetes technology & therapeutics, 2000,Spring, Volume: 2, Issue:1

    Topics: Alginates; Animals; Biocompatible Materials; Biomedical Engineering; Capsules; Cell Transplantation; Diabetes Mellitus, Type 1; Glucuronic Acid; Hexuronic Acids; Humans; Injections; Insulin; Insulin Secretion; Islets of Langerhans Transplantation; Polylysine; Transplantation, Autologous

2000

Trials

2 trial(s) available for glucuronic acid and Autoimmune Diabetes

ArticleYear
Sustained function of alginate-encapsulated human islet cell implants in the peritoneal cavity of mice leading to a pilot study in a type 1 diabetic patient.
    Diabetologia, 2013, Volume: 56, Issue:7

    Topics: Alginates; Animals; Blood Glucose; C-Peptide; Cells, Cultured; Diabetes Mellitus, Type 1; Female; Glucuronic Acid; Hexuronic Acids; Humans; Islets of Langerhans; Islets of Langerhans Transplantation; Mice; Middle Aged; Peritoneal Cavity

2013
Efficacy and tolerance of calcium alginate versus vaseline gauze dressings in the treatment of diabetic foot lesions.
    Diabetes & metabolism, 2002, Volume: 28, Issue:3

    Topics: Age of Onset; Alginates; Bandages; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetic Foot; Female; Follow-Up Studies; France; Glucuronic Acid; Glycated Hemoglobin; Hexuronic Acids; Humans; Male; Middle Aged; Petrolatum; Time Factors; Treatment Outcome; Wound Healing

2002

Other Studies

41 other study(ies) available for glucuronic acid and Autoimmune Diabetes

ArticleYear
Tunable injectable alginate-based hydrogel for cell therapy in Type 1 Diabetes Mellitus.
    International journal of biological macromolecules, 2018, Volume: 107, Issue:Pt A

    Topics: Alginates; Animals; Biocompatible Materials; Cell- and Tissue-Based Therapy; Diabetes Mellitus, Type 1; Glucuronic Acid; Hexuronic Acids; Humans; Hydrogel, Polyethylene Glycol Dimethacrylate; Insulin; Islets of Langerhans; Rats

2018
Microencapsulation for cell therapy of type 1 diabetes mellitus: The interplay between common beliefs, prejudices and real progress.
    Journal of diabetes investigation, 2018, Volume: 9, Issue:2

    Topics: Alginates; Animals; Biopolymers; Cell- and Tissue-Based Therapy; Diabetes Mellitus, Type 1; Drug Compounding; Glucuronic Acid; Hexuronic Acids; Humans; Islets of Langerhans Transplantation

2018
Islet encapsulation: advances and obstacles.
    Diabetologia, 2013, Volume: 56, Issue:7

    Topics: Alginates; Animals; Capsules; Diabetes Mellitus, Type 1; Glucuronic Acid; Graft Survival; Hexuronic Acids; Humans; Islets of Langerhans Transplantation

2013
Injectable nano-network for glucose-mediated insulin delivery.
    ACS nano, 2013, May-28, Volume: 7, Issue:5

    Topics: Alginates; Animals; Biocompatible Materials; Chitosan; Dextrans; Diabetes Mellitus, Type 1; Drug Carriers; Glucose; Glucuronic Acid; Hexuronic Acids; Humans; Injections; Insulin; Male; Mice; Mice, Inbred C57BL; Nanoparticles

2013
Xenotransplantation of exendin-4 gene transduced pancreatic islets using multi-component (alginate, poly-L-lysine, and polyethylene glycol) microcapsules for the treatment of type 1 diabetes mellitus.
    Journal of biomaterials science. Polymer edition, 2013, Volume: 24, Issue:18

    Topics: Alginates; Animals; Capsules; Diabetes Mellitus, Type 1; Drug Carriers; Exenatide; Glucose; Glucuronic Acid; Hexuronic Acids; Insulin; Insulin Secretion; Islets of Langerhans; Male; Mice; Microspheres; Peptides; Polyethylene Glycols; Polylysine; Rats; Rats, Sprague-Dawley; Static Electricity; Tissue Survival; Transduction, Genetic; Transplantation, Heterologous; Venoms

2013
Encapsulate this.
    Nature medicine, 2014, Volume: 20, Issue:1

    Topics: Alginates; Capsules; Diabetes Mellitus, Type 1; Glucuronic Acid; Hexuronic Acids; Humans; Insulin; Islets of Langerhans; Islets of Langerhans Transplantation

2014
An advanced microencapsulated system: a platform for optimized oral delivery of antidiabetic drug-bile acid formulations.
    Pharmaceutical development and technology, 2015, Volume: 20, Issue:6

    Topics: Administration, Oral; Alginates; Animals; Capsules; Cholic Acid; Diabetes Mellitus, Type 1; Drug Carriers; Drug Compounding; Excipients; Gliclazide; Glucuronic Acid; Hexuronic Acids; Hypoglycemic Agents; Rats

2015
Novel artificial cell microencapsulation of a complex gliclazide-deoxycholic bile acid formulation: a characterization study.
    Drug design, development and therapy, 2014, Volume: 8

    Topics: Alginates; Animals; Artificial Cells; Capsules; Chemistry, Pharmaceutical; Deoxycholic Acid; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Excipients; Gliclazide; Glucuronic Acid; Hexuronic Acids; Hypoglycemic Agents; Particle Size; Rats; Rheology

2014
Release and swelling studies of an innovative antidiabetic-bile acid microencapsulated formulation, as a novel targeted therapy for diabetes treatment.
    Journal of microencapsulation, 2015, Volume: 32, Issue:2

    Topics: Alginates; Animals; Capsules; Deoxycholic Acid; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Drug Delivery Systems; Gliclazide; Glucuronic Acid; Hexuronic Acids; Hypoglycemic Agents; Rats

2015
The role of the bile acid chenodeoxycholic acid in the targeted oral delivery of the anti-diabetic drug gliclazide, and its applications in type 1 diabetes.
    Artificial cells, nanomedicine, and biotechnology, 2016, Volume: 44, Issue:6

    Topics: Administration, Oral; Alginates; Capsules; Chenodeoxycholic Acid; Diabetes Mellitus, Type 1; Drug Compounding; Gliclazide; Glucuronic Acid; Hexuronic Acids; Humans; Hypoglycemic Agents

2016
Long-term Efficacy and Biocompatibility of Encapsulated Islet Transplantation With Chitosan-Coated Alginate Capsules in Mice and Canine Models of Diabetes.
    Transplantation, 2016, Volume: 100, Issue:2

    Topics: Alginates; Animals; Barium Compounds; Blood Glucose; Cell Adhesion; Chitosan; Chlorides; Coated Materials, Biocompatible; Cross-Linking Reagents; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Dogs; Female; Fibrosis; Galactosyltransferases; Glucuronic Acid; Graft Survival; Heterografts; Hexuronic Acids; Insulin; Islets of Langerhans; Islets of Langerhans Transplantation; Male; Mice; Mice, Knockout; Porosity; RAW 264.7 Cells; Swine; Swine, Miniature; Time Factors; Transplantation, Homologous

2016
A comprehensive study of novel microcapsules incorporating gliclazide and a permeation enhancing bile acid: hypoglycemic effect in an animal model of Type-1 diabetes.
    Drug delivery, 2016, Volume: 23, Issue:8

    Topics: Alginates; Animals; Bile Acids and Salts; Blood Glucose; Capsules; Cell Survival; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Disease Models, Animal; Drug Compounding; Excipients; Gliclazide; Glucuronic Acid; Hexuronic Acids; Hypoglycemic Agents; Particle Size; Solubility; Taurocholic Acid

2016
VEGF-conjugated alginate hydrogel prompt angiogenesis and improve pancreatic islet engraftment and function in type 1 diabetes.
    Materials science & engineering. C, Materials for biological applications, 2016, Volume: 59

    Topics: Alginates; Animals; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Glucuronic Acid; Hexuronic Acids; Hydrogel, Polyethylene Glycol Dimethacrylate; Islets of Langerhans; Islets of Langerhans Transplantation; Male; Mice; Mice, Inbred C57BL; Neovascularization, Physiologic; Vascular Endothelial Growth Factor A

2016
Boost for Alginate Encapsulation in Beta Cell Transplantation.
    Trends in endocrinology and metabolism: TEM, 2016, Volume: 27, Issue:5

    Topics: Alginates; Animals; Diabetes Mellitus, Type 1; Drug Compounding; Embryonic Stem Cells; Glucuronic Acid; Hexuronic Acids; Humans; Insulin-Secreting Cells; Islets of Langerhans Transplantation; Mice

2016
Developing a Rapid Algorithm to Enable Rapid Characterization of Alginate Microcapsules.
    Cell transplantation, 2017, 05-09, Volume: 26, Issue:5

    Topics: Alginates; Algorithms; Animals; Capsules; Diabetes Mellitus, Type 1; Glucuronic Acid; Hexuronic Acids; Humans; Islets of Langerhans Transplantation

2017
Polymeric Materials for Perm-Selective Coating of Alginate Microbeads.
    Methods in molecular biology (Clifton, N.J.), 2017, Volume: 1479

    Topics: Alginates; Animals; Capsules; Cells, Immobilized; Diabetes Mellitus, Type 1; Drug Compounding; Glucuronic Acid; Hexuronic Acids; Islets of Langerhans; Islets of Langerhans Transplantation; Particle Size; Peptides; Permeability; Polylysine; Rats, Sprague-Dawley

2017
Microencapsulation in Clinical Islet Xenotransplantation.
    Methods in molecular biology (Clifton, N.J.), 2017, Volume: 1479

    Topics: Alginates; Animals; Capsules; Cell Separation; Cells, Immobilized; Clinical Trials as Topic; Diabetes Mellitus, Type 1; Glucuronic Acid; Graft Survival; Hexuronic Acids; Humans; Islets of Langerhans; Islets of Langerhans Transplantation; Swine; Transplantation, Heterologous; Transplantation, Homologous

2017
Diabetes: Encapsulating the problem.
    Nature, 2016, 12-07, Volume: 540, Issue:7632

    Topics: Alginates; Animals; Cell- and Tissue-Based Therapy; Diabetes Mellitus, Type 1; Glucuronic Acid; Graft Rejection; Hexuronic Acids; Humans; Induced Pluripotent Stem Cells; Islets of Langerhans; Islets of Langerhans Transplantation

2016
Encapsulation of human islets in novel inhomogeneous alginate-ca2+/ba2+ microbeads: in vitro and in vivo function.
    Artificial cells, blood substitutes, and immobilization biotechnology, 2008, Volume: 36, Issue:5

    Topics: Alginates; Animals; Barium; Blood Glucose; Calcium; Cell Survival; Cells, Cultured; Diabetes Mellitus, Type 1; Drug Compounding; Female; Glucose Tolerance Test; Glucuronic Acid; Hexuronic Acids; Humans; Immunosuppression Therapy; Insulin; Insulin Secretion; Islets of Langerhans; Islets of Langerhans Transplantation; Male; Mice; Mice, Nude; Microspheres; Organ Preservation

2008
Xenogeneic islet transplantation of microencapsulated porcine islets for therapy of type I diabetes: long-term normoglycemia in STZ-diabetic rats without immunosuppression.
    Pediatric surgery international, 2008, Volume: 24, Issue:12

    Topics: Alginates; Animals; Biocompatible Materials; Blood Glucose; Diabetes Mellitus, Type 1; Disease Models, Animal; Drug Compounding; Glucuronic Acid; Hexuronic Acids; Immunosuppression Therapy; Islets of Langerhans Transplantation; Rats; Rats, Wistar; Swine; Time Factors; Transplantation, Heterologous

2008
Safety and viability of microencapsulated human islets transplanted into diabetic humans.
    Diabetes care, 2009, Volume: 32, Issue:10

    Topics: Adult; Alginates; Blood Glucose; C-Peptide; Capsules; Cell Survival; Diabetes Mellitus, Type 1; Female; Glucuronic Acid; Hexuronic Acids; Humans; Islets of Langerhans Transplantation; Male; Middle Aged

2009
Bioactive long-term release from biodegradable microspheres preserves implanted ALG-PLO-ALG microcapsules from in vivo response to purified alginate.
    Pharmaceutical research, 2010, Volume: 27, Issue:2

    Topics: Absorbable Implants; Alginates; Animals; Biological Availability; Capsules; Delayed-Action Preparations; Diabetes Mellitus, Type 1; Glucuronic Acid; Hexuronic Acids; Mice; Microspheres; Particle Size; Peptides

2010
The humanized NOD/SCID mouse as a preclinical model to study the fate of encapsulated human islets.
    The review of diabetic studies : RDS, 2010,Spring, Volume: 7, Issue:1

    Topics: Alginates; Animals; Ascitic Fluid; Biocompatible Materials; Blood Glucose; Chemokines; Cytokines; Diabetes Mellitus, Type 1; Disease Models, Animal; Female; Glucuronic Acid; Graft Rejection; Hexuronic Acids; Humans; Islets of Langerhans Transplantation; Mice; Mice, Inbred NOD; Mice, SCID; T-Lymphocytes; Transplantation, Heterologous

2010
Correction of hyperglycemia in type 1 diabetic models by transplantation of encapsulated insulin-producing cells derived from mouse embryo progenitor.
    The Journal of endocrinology, 2011, Volume: 208, Issue:3

    Topics: Alginates; Animals; Capsules; Cell Differentiation; Cell Proliferation; Cells, Cultured; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Disease Models, Animal; Embryonic Stem Cells; Glucose Tolerance Test; Glucuronic Acid; Hexuronic Acids; Hyperglycemia; Insulin; Insulin Secretion; Insulin-Secreting Cells; Male; Mice; Mice, Inbred BALB C; Treatment Outcome

2011
Improving the efficacy of type 1 diabetes therapy by transplantation of immunoisolated insulin-producing cells.
    Human cell, 2011, Volume: 24, Issue:2

    Topics: Alginates; Animals; Bone Marrow Cells; Cell Differentiation; Cell Separation; Cells, Cultured; Diabetes Mellitus, Type 1; Disease Models, Animal; Fetal Blood; Glucuronic Acid; Hexuronic Acids; Humans; Insulin; Insulin Secretion; Male; Mesenchymal Stem Cell Transplantation; Mesenchymal Stem Cells; Mice; Transplantation, Heterologous; Transplantation, Homologous

2011
Encapsulated pancreatic progenitors derived from human embryonic stem cells as a therapy for insulin-dependent diabetes.
    Diabetes/metabolism research and reviews, 2011, Volume: 27, Issue:8

    Topics: Alginates; Animals; Blood Glucose; Capsules; Cell Differentiation; Diabetes Mellitus, Type 1; Embryonic Stem Cells; Glucuronic Acid; Hexuronic Acids; Humans; Insulin; Insulin-Secreting Cells; Mice; Mice, Inbred NOD; Mice, SCID; Swine; Transplantation, Heterologous

2011
A three-dimensional microfluidic approach to scaling up microencapsulation of cells.
    Biomedical microdevices, 2012, Volume: 14, Issue:3

    Topics: Alginates; Animals; Cell Culture Techniques; Cells, Immobilized; Chronic Disease; Diabetes Mellitus, Type 1; Drug Delivery Systems; Equipment Design; Glucuronic Acid; Hexuronic Acids; Islets of Langerhans; Liver Diseases; Liver Transplantation; Microfluidic Analytical Techniques; Microspheres; Rats

2012
Optimized parameters for microencapsulation of pancreatic islet cells: an in vitro study clueing on islet graft immunoprotection in type 1 diabetes mellitus.
    Transplant immunology, 2004, Volume: 13, Issue:4

    Topics: Alginates; Animals; Capsules; Cytokines; Diabetes Mellitus, Type 1; Glucuronic Acid; Graft Rejection; Hexuronic Acids; Islets of Langerhans; Islets of Langerhans Transplantation; Macrophages; Male; Nitric Oxide; Rats; Rats, Inbred Lew; Rats, Inbred WF

2004
Effect of alginate composition and purity on alginate microspheres.
    Journal of microencapsulation, 2004, Volume: 21, Issue:8

    Topics: Alginates; Diabetes Mellitus, Type 1; Drug Compounding; Glucuronic Acid; Humans; Islets of Langerhans; Islets of Langerhans Transplantation; Microspheres; Particle Size

2004
Emulsion strategies in the microencapsulation of cells: pathways to thin coherent membranes.
    Biotechnology and bioengineering, 2005, Oct-05, Volume: 92, Issue:1

    Topics: Alginates; Biocompatible Materials; Biotechnology; Calcium; Calcium Chloride; Capsules; Cell Adhesion; Cell Line; Cell Line, Tumor; Diabetes Mellitus, Type 1; Drug Compounding; Emulsions; Glucuronic Acid; Hexuronic Acids; Humans; Islets of Langerhans Transplantation; Membranes; Microscopy; Microscopy, Confocal; Microscopy, Fluorescence; Models, Chemical; Peptides; Polylysine

2005
Use of glucose-responsive material to regulate insulin release from constitutively secreting cells.
    Biotechnology and bioengineering, 2006, Apr-20, Volume: 93, Issue:6

    Topics: Alginates; Animals; Cell Line; Cell Line, Tumor; Cell Survival; Concanavalin A; Diabetes Mellitus, Type 1; Glucose; Glucuronic Acid; Glycogen; Hexuronic Acids; Humans; Hydrogels; Insulin; Insulin Secretion; Membranes, Artificial; Pancreas, Artificial; Phase Transition; Polycarboxylate Cement; Tissue Engineering; Transfection

2006
'Seaweed' human islet clinical trials underway.
    Australian nursing journal (July 1993), 2006, Volume: 13, Issue:9

    Topics: Alginates; Animals; Biocompatible Materials; Capsules; Clinical Trials as Topic; Diabetes Mellitus, Type 1; Glucuronic Acid; Hexuronic Acids; Humans; Islets of Langerhans Transplantation; Tissue Donors; Treatment Outcome

2006
Artificial pancreas to treat type 1 diabetes mellitus.
    Methods in molecular medicine, 2007, Volume: 140

    Topics: Alginates; Animals; Biocompatible Materials; Capsules; Cell Culture Techniques; Diabetes Mellitus, Type 1; Female; Glucuronic Acid; Hexuronic Acids; Humans; Insulin; Islets of Langerhans Transplantation; Male; Pancreas, Artificial; Tissue Engineering; Transplantation, Heterologous; Treatment Outcome

2007
Elevated L-xylulose concentrations in serum: a difference between type I and type II diabetes.
    Metabolism: clinical and experimental, 1984, Volume: 33, Issue:1

    Topics: Blood Glucose; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Glucuronates; Glucuronic Acid; Growth Hormone; Humans; Inositol; Pentoses; Xylulose

1984
TNF production from peripheral blood mononuclear cells in diabetic patients after stimulation with alginate and lipopolysaccharide.
    Scandinavian journal of immunology, 1996, Volume: 43, Issue:3

    Topics: Adolescent; Adult; Alginates; Biocompatible Materials; Diabetes Mellitus, Type 1; Female; Glucuronic Acid; Hexuronic Acids; Humans; Leukocytes, Mononuclear; Lipopolysaccharides; Male; Middle Aged; Tumor Necrosis Factor-alpha; Uronic Acids

1996
Improved biocompatibility but limited graft survival after purification of alginate for microencapsulation of pancreatic islets.
    Diabetologia, 1997, Volume: 40, Issue:3

    Topics: Alginates; Animals; Biocompatible Materials; Blood Glucose; Capsules; Cell Separation; Cells, Cultured; Diabetes Mellitus, Type 1; Glucose Tolerance Test; Glucuronic Acid; Graft Survival; Hexuronic Acids; Islets of Langerhans; Islets of Langerhans Transplantation; Male; Polylysine; Rats; Rats, Inbred BB; Rats, Inbred Lew; Rats, Inbred Strains; Time Factors; Transplantation, Homologous; Transplantation, Isogeneic

1997
Development of biocompatible barium alginate microcapsules.
    Transplantation proceedings, 1997, Volume: 29, Issue:4

    Topics: Alginates; Animals; Biocompatible Materials; Blood Glucose; Capsules; Diabetes Mellitus, Type 1; Erythrocyte Transfusion; Glucuronic Acid; Hexuronic Acids; Humans; Islets of Langerhans Transplantation; Peritoneal Cavity; Rats; Rats, Inbred BB; Rats, Wistar; Transplantation, Heterologous

1997
Encapsulated beta-islet cells as a bioartificial pancreas to treat insulin-dependent diabetes during pregnancy.
    American journal of obstetrics and gynecology, 1997, Volume: 177, Issue:4

    Topics: Alginates; Animals; Biocompatible Materials; Blood Glucose; Congenital Abnormalities; Diabetes Mellitus, Type 1; Female; Glucuronic Acid; Hexuronic Acids; Insulin; Insulin Secretion; Islets of Langerhans; Islets of Langerhans Transplantation; Male; Mice; Mice, Inbred BALB C; Microspheres; Pancreas, Artificial; Pregnancy; Pregnancy in Diabetics; Prolactin; Rats; Rats, Inbred Lew

1997
Complete protection of islets against allorejection and autoimmunity by a simple barium-alginate membrane.
    Diabetes, 2001, Volume: 50, Issue:8

    Topics: Alginates; Animals; Autoimmunity; Biocompatible Materials; Blood Glucose; C-Peptide; Capsules; Coculture Techniques; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Glucose Tolerance Test; Glucuronic Acid; Graft Rejection; Graft Survival; Hexuronic Acids; Islets of Langerhans; Islets of Langerhans Transplantation; Male; Mice; Mice, Inbred BALB C; Mice, Inbred NOD; Mice, Inbred Strains; Spleen; Subrenal Capsule Assay; T-Lymphocytes; Time Factors; Transplantation, Homologous; Transplantation, Isogeneic

2001
The effect of capsule composition on the viability and biocompatibility of sodium alginate/poly-L-lysine encapsulated islets.
    Transplantation proceedings, 1992, Volume: 24, Issue:3

    Topics: Alginates; Animals; Capsules; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Glucuronic Acid; Hexuronic Acids; Insulin Infusion Systems; Islets of Langerhans Transplantation; Polylysine; Rats; Rats, Inbred BB; Rats, Inbred Strains; Rats, Nude

1992
Immunoisolation of pancreatic B cells by microencapsulation. An in vitro study.
    Diabetologia, 1985, Volume: 28, Issue:10

    Topics: Alginates; Animals; Antibodies; Arginine; Chromium Radioisotopes; Complement System Proteins; Cytotoxicity Tests, Immunologic; Diabetes Mellitus, Type 1; Glucose; Glucuronic Acid; Hexuronic Acids; Humans; Insulin; Insulin Secretion; Islets of Langerhans; Islets of Langerhans Transplantation; Permeability; Rats; Rats, Inbred Strains; Theophylline

1985